Ependymomas are the commonest type of spinal glioma which represent a group of relatively benign tumours. Myxopapillary ependymoma (MPE) is a common variant found within the distal spinal cord around the conus. These two entities are clearly differentiated on the basis of their characteristic histological and molecular features. Rare variants of MPE's are described in the literature to have the propensity to metastasise and grow in extraspinal locations despite appearing histologically identical to their more benign relatives. Here, we describe two unusual cases of MPE and utilise DNA methylation analyses to compare their molecular signatures with known molecular subtypes of ependymoma in an attempt to distinguish whether these tumours represent a unique subset of disease.
Introduction
Ependymomas are the most common type of spinal cord glioma, accounting for some 60% of cases [1, 2] . Myxopapillary ependymomas (MPE) are typically described as a benign subgroup, which almost exclusively involve the distal spinal cord and filum terminale. They occur much more commonly in adults than children, and in the former have an excellent prognosis. Contemporary treatment regimes in adults solely involve gross total resection, although some groups advocate for adjuvant radiotherapy [3] . MPE may rarely exhibit anaplastic features [4] [5] [6] or occur outside the spinal canal within the subcutaneous tissue [7] in both adult and paediatric patients. These unusual anaplastic variants have been reported to metastasise, both within the central nervous system and extracranially [8] [9] [10] . Dissemination prior to surgical intervention is documented in the paediatric population, but is an uncommon feature for adult spinal MPE [11, 12] . Furthermore, in contrast to adults, MPEs tend to be extraspinal in children and more benign than the intra-spinal cases [13] .
Classical spinal ependymomas and MPE are histologically distinct and genomic profiling has revealed that the two entities have characteristic molecular signatures that correlate with differences in their clinical behaviour [14, 15] . However, what is less clear is why there is a wide variation in the phenotypic presentation of MPE in adults and children. Here we investigate two atypical cases of pediatric MPE and aim to molecular clarify if they are distinct from other ependymomas.
Case reports

Case 1
A previously well 12-year-old female presented with a tender mass at the superior aspect of the natal cleft, present for 2 months prior to attendance at the hospital. On the day of presentation, the patient had noticed the painful lump while lying down at school. Neurological examination was normal. Magnetic resonance imaging (MRI) revealed a well circumscribed 47 Â 21 Â 44 mm contrast enhancing mass intimately related to the sacrum/coccyx. (Fig. 1A) . A staging CT of the chest abdomen and pelvis was normal. Blood tumour marker assessment revealed mildly elevated neuron-specific enolase (18.4 ng/ml), normal alpha-fetoprotein (AFP < 3 ng/ml) and normal beta human chorionic gonadotrophin (b-hCG < 1 ng/ml). The patient underwent a wide local excision of the lesion in continuity with the coccyx two days later.
Histopathological analysis revealed a circumscribed nodular lesion characterised by cuboidal to elongated tumour cells radially arranged in a papillary manner around vascularised stromal cores. Mucoid material was present between tumour cells and the blood vessels. There were areas of mild nuclear pleomorphism with low mitotic activity (up to two per high power field (HPF)) and no nuclear atypia or high-grade features. The diagnosis was myxopapillary ependymoma (WHO Grade I). The patient made an uneventful post-operative recovery. An MRI at 12 months after resection (Fig. 1B ) revealed no evidence of local recurrence.
Case 2
A 14-year-old male presented to his general practitioner with a six-week history of worsening lower back pain, which was associated with one week of sciatic pain. Neurological examination was normal. A spinal MRI showed a well-defined 45 Â 21 mm soft tissue mass filling the thecal sac and central canal at L5 level. A further small nodule at the thecal tip (S2 level) was also noted. Both lesions were mildly contrast enhancing ( Fig. 2 A and B) .
The patient underwent semi-elective L4 to S2 laminectomies to remove the tumours. The dura was opened midline under magnification. The filum terminale was sectioned and the blood supply to the tumour from the filum vessels was interrupted. The tumour was internally debulked with ultrasonic aspiration and gross total resection of both lesions was obtained. At the time of surgery, the surgeon described the tumour as solid and haemorrhagic, protruding initially through the dural sac and requiring ultrasonic aspiration and suction to remove. The postoperative period was unremarkable, and the patient was discharged well with no neurological deficits. A follow-up MRI seven weeks after surgery confirmed a complete resection (Fig. 2C and D) . Pathological examination of the lesion revealed a grey-tan solid tumour. Microscopic sections showed a cellular neoplasm with a predominantly pseudo-papillary architectural growth pattern comprised of discohesive aggregates of tumour cells with central areas of cystic change containing basophilic myxoid material (Fig. 3A) . Interspersed papillary structures with fibrovascular cores were occasionally surrounded by myxoid material and a peripheral layer of radially arranged tumour cells. The neoplastic cells had round to oval nuclei with fine chromatin, indistinct nucleoli and variable amounts of eosinophilic cytoplasm. Mild nuclear pleomorphism was noted, with up to nine mitotic figures per 10 high power fields. Necrosis was not detected, but focal proliferation of small blood vessels was seen. The cells stained positively for GFAP, vimentin and CD99 with some positivity for S100 and p53, while epithelial membrane antigen (EMA) was negative. Staining for Ki67, a proliferation marker, was identified in 10% of neoplastic cells (Fig. 3C) . These findings were consistent with MPE. 
Genomic profiling
MPEs typically have a favourable prognosis and are classified as WHO Grade I [16] . However, spinal MPE have a higher incidence of relapse and metastases in paediatric patients [17, 18] . These two cases of spinal MPE in children exhibit markedly different indicators of proliferation, thus we sought to investigate them further to determine if they were distinct molecular entities. To compare the genomic DNA copy number profiles of these MPEs with other reported cases of ependymoma, we hybridised the genomic DNA with Illumina HumanMethylation450 BeadChip arrays. Data was then compared with probe intensity values from other ependymomas using the 'Conumee' package in R as previously described [19] (http://bioconductor.org/packages/release/bioc/html/conumee. html).
Case 1 demonstrated broad losses of chromosomes 3, 6 and 13, and gains on chromosome 4, 9, 18 and 20 (Fig. 4A) . Case 2 exhibited losses on chromosomes 1, 2, 10, 12 and 14, with gain of chromosome 9 (Fig. 4B) . Similarities between the two cases included gain of chromosome 9.
We analysed the genome-wide DNA methylation profiles of both cases and compared these with 53 reference cases consisting of 22 spinal ependymomas and 31 MPEs (Fig. 5) [20] . Consistent with the histology of both tumours, unsupervised hierarchical clustering showed that these samples are epigenetically similar to other MPEs without forming a separate group, and clearly distinct from spinal ependymomas.
Discussion
Ependymomas comprise approximately 60% of spinal glial series tumours and up to 90% of primary tumours of the cauda equina and filum terminale [2, 21] . MPE is a distinct subgroup of ependymoma originally described in 1932 by Kernohan on the basis of histological appearance. These classically benign WHO grade I lesions represent 13% of ependymal tumours in adults but are less common in children [22] . Although slow growing, incomplete resection has been associated with local recurrence in both adults and children [23, 24] . Moreover, up to a third of treatment failures occur at distant sites [22] and metastases to bone, bone marrow, lung, cervical lymph nodes, liver and paranasal sinuses have been reported [24, 25] . In children, spinal MPE appears to be more aggressive than in adults [13, 22, 26] with higher rates of spinal and cranial dissemination [27] .
Although anaplastic variants of MPE are not specifically graded by the WHO, features of anaplasia are recognised. The anaplastic variant reported here (Case 2) showed mild nuclear pleomorphism with up to nine mitoses per ten HPF, vascular endothelial proliferation and a Ki67 index of 10%. The few case reports that have been published describe hyper-cellularity, nuclear pleomorphism, punctate necrosis, endothelial cell proliferation and a Ki67 labelling index of between 10.1% and 70% [4] [5] [6] . Outcomes for these cases are summarised in Table 1 , where all three patients had a favourable outcome.
Recent advances in genomic profiling techniques have enabled rapid identification of specific and recurrent chromosomal aberrations that correlate with location, histological subtype and grade [28, 29] . One such study for ependymoma described array comparative genomic hybridisation (aCGH) data for 45 cases arising in heterogeneous locations in adults and children [15] . Three of the five adult spinal MPEs (there were no paediatric MPEs in the cohort) had a specific signature defined by concurrent gains of chromosomes 5, 7, 9, 16 and 18 that differentiated these cases from all of the other types of ependymoma in the dataset (P = .0007). We calculated DNA copy number changes in the cases reported here using the sum of both methylated and unmethylated signals from the 450K methylation arrays, which revealed unique profiles neither of which was consistent with the alterations found by Rousseau et al. Broadly, these findings may reflect characteristic genomic differences between adult and paediatric MPEs, which may in turn be related to the known differences between adult and paediatric clinical presentation of the disease.
Mack et al. recently used gene expression profiling to show there are clear biological and molecular differences that delineate spinal MPE from grade II spinal ependymomas, a finding which correlated with differences in the histological and clinical phenotypes for these tumours [14] . When compared to a large library of previously genetically-characterised paediatric spinal ependymomas and MPEs [20] , Case 1 and Case 2 had methylation profiles most similar to standard spinal MPEs.
Despite the variation in histological appearance and location, the methylation profiling conducted here suggests that extraspinal MPE and MPE with anaplastic features may be phenotypic variations of standard spinal MPE, and not necessarily unique subtypes of ependymoma within the paediatric population. However, the distinct chromosomal signatures of our two cases compared with adult spinal MPEs found in other studies, and the very different clinical presentation is consistent with a different underlying biology in adult and paediatric MPEs which warrants further investigation. The findings in this report highlight the importance of further collaborative efforts to generate larger patient cohorts for the analysis of rare MPE subtypes.
